Humana: stocks, financial statements

Disable ads for free
Dividends News
Favorites

Humana Inc. engages in the provision of health insurance services. The firm operates through the following segments: Retail, Group and Specialty, Healthcare Services, and Individual Commercial. The Retail segment consists of products sold on a retail basis to individuals including medical and supplemental benefit plans such as Medicare, and State-based Medicaid contracts. The Group and Specialty segment contains employer group fully-insured commercial medical products and specialty health insurance benefits marketed to individuals and groups, including dental, vision, military services and other supplemental health & voluntary insurance benefits. The Healthcare Services segment offer services such as pharmacy solutions, provider services, clinical care, predictive modeling and informatics services to other Humana businesses, as well as external health plan members, external health plans, and other employers.. The Individual Commercial segment includes Individual Commercial products marketed under the HumanaOne brand. The company was founded by David A. Jones, Sr. and Wendell Cherry in 1961 and is headquartered in Louisville, KY.

  • HUM Ticker
  • NYSE Exchange
  • 43,600 Employees
5 rated
  • $412.78, +$8.95 (+2.22%) Previous Close
  • 520,404 Previous Volume
  • $213.29 / $452.01 52 week low / high
  • -8.68% Percent off 52 week high
  • 2020-12-04 Updated
  • 0.59% Dividend Yield (trailing)
  • 0.61% Dividend Yield (forward)
  • 0 Public float
  • 132,341,451 Outstanding shares
  • 12.87 P/E
  • 53.44 B Market Cap
Disable ads for free

Financial statements — Humana

The information is not 100% up-to-date. There may be errors or missing information. Some information is often missing, and, although there are almost no errors, I can't rule them out. Right now, I'm looking for a supplier of high-quality information, but so far what I'm finding is expensive (about $2000 a year). You can help my project here.
19 ← 15 2019 2018 2017 2016 2015
Total Revenue
Cost Of Revenue
Gross Profit
Research and Development
Selling General and Admin
Operating Expense
Operating Income
Other Income Expense Net
EBIT
Interest Income
240M 220M 240M 190M 190M
Pretax Income
3.5B 2.1B 4B 1.6B 2.4B
Income Tax
760M 390M 1.6B 940M 1.2B
Minority Interest
0 0 0 0 0
Net Income
2.7B 1.7B 2.4B 610M 1.3B
Net Income Basic
2.7B 1.7B 2.4B 610M 1.3B
19 ← 15 2019 2018 2017 2016 2015
Current cash
Short term investments
11B 10B 9.6B 7.6B 7.3B
Receivables
Inventory
Other current assets
Current assets
17B 14B 15B 15B 14B
Long term investments
1.1B 1B
Property plant equipment
2.4B 1.7B 1.6B 1.5B 1.4B
Goodwill
3.9B 3.9B 3.3B 3.3B 3.3B
Intangible assets
180M 250M 230M 280M 360M
Other assets
4.8B 4.4B 3.8B 4.2B 5.9B
Total assets
29B 26B 28B 26B 25B
Accounts payable
3.6B 3.1B 4.1B 2.5B 2.2B
Current long term debt
Other current liabilities
6.1B 5B 4.8B 4.8B 5.3B
Total current liabilities
11B 9.8B 9B 7.5B 7.8B
Long term debt
5.3B 4.4B 4.8B 3.8B 3.8B
Other liabilities
4.1B 3.7B 4.4B 2.9B 2.7B
Minority Interest
0 0 0 0 0
Total Liabilities
17B 15B 18B 15B 15B
Common stock
130M 140M 140M 150M 150M
Retained earning
17B 15B 14B 11B 11B
Treasury stock
370K 360K 440K 590K 370K
Capital surplus
2.8B 2.5B 2.4B 2.6B 2.5B
Shareholder equity
12B 10B 9.8B 11B 10B
Net tangible assets
3.4B 1.5B 2.5B 3.4B 3.1B
19 ← 15 2019 2018 2017 2016 2015
Net Income
2.7B 1.7B 2.4B 610M 1.3B
Depreciation
580M 530M 490M 470M 450M
Changes in receivables
Changes in inventories
Cash change
1.7B -1.7B 170M 1.3B 640M
Cash flow
5.3B 2.2B 4.1B 1.9B 870M
Capital expenditures
-740M -610M -530M -530M -520M
Investments
-540M -1.3B -2.4B -830M -180M
Investing activity other
Total investing cash flows
-1.3B -3.1B -2.9B -1.4B 320M
Dividends paid
-290M -270M -220M -180M -170M
Net borrowings
-420M 1.1B 830M -91M 270M
Other financing cash flows
-570M -610M 1.8B 1.1B -280M
Cash flow financing
-2.3B -790M -950M 730M -550M
Exchange rate effect
Disable ads for free
Disable ads for free